17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Malignant Melanoma

Clinical trial NCT00104897 · COMPLETED

Trial details

NCT number: NCT00104897
Sponsor: Cancer Research UK
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma (Skin)

Start date: 2005-03-01
Primary completion: 2010-11-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.